Condition

Aldosterone-Producing Adenoma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Aldosterone-Producing Adenoma clinical trials that are recruiting, at sites in 3 countries (most in China (1), South Korea (1), Norway (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Aldosterone-Producing Adenoma clinical trials

StudyPhaseWhereStatusRegistered
Using Gallium-68 Pentixafor PET-CT to improve surgery outcomes in primary aldosteronism — Seoul, Gangnam-gu and 1 other locations Recruiting Jun 18, 2025
Comparing ultrasound-guided ablation and laparoscopic surgery for adrenal tumors — Guangzhou, Guangdong Recruiting Aug 15, 2023
Endoscopic ultrasound-guided radiofrequency ablation for adrenal tumors in primary aldosteronism — Bergen Recruiting May 10, 2022

All recruiting trials (3)

Related topics

Primary AldosteronismAdrenalectomyHypercortisolismRadiofrequency Ablation

Quick answers

How many Aldosterone-Producing Adenoma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), South Korea (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.